Recurrent Breast Cancer Completed Phase 3 Trials for Paclitaxel (DB01229)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003440Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or MetastaticTreatment